首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1370519

口乾症（口乾症）治療市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年10月15日 | 出版商:

IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

市場概況：

2022年，全球口乾症（口乾症）治療市場規模達7.14億美元。展望未來，IMARC Group預計到2028年市場規模將達到8.93億美元，2023-2028年年複合成長率（CAGR）為3.6 % 。

口乾症或口乾是指口腔乾燥的症狀或感覺，通常是由於唾液量減少引起的。這種情況是由頸部和頭部放射性的不利影響、抗焦慮藥物的消耗增加、脫水、糖尿病和阿茲海默症引發的。可以在唾液筆或興奮劑、人工唾液、處方藥和家庭療法（包括喝水和滋潤嘴唇）的支持下進行治療。除此之外，醫生對唾液腺的早期診斷以及使用推薦的口腔保濕產品（例如非處方（OTC）漱口水）可以幫助潤滑口腔。這些治療可緩解不適，預防嚴重併發症，修復味覺障礙，並減輕口臭和味覺障礙。因此，一些醫院和診所使用口乾療法來治療唾液腺功能下降。

口乾症（口乾症）治療市場趨勢：

由於放射治療和化療的藥物副作用，口乾的發生率不斷增加，特別是在老年人口中，以及對口乾緩解產品的需求不斷增加，主要推動了市場的成長。此外，一些處方牙膏、維生素軟糖和治療乾燥綜合症、阿茲海默症和導致口乾症的人類免疫缺陷病毒 (HIV) 的藥物的使用量不斷增加，也是另一個生長誘導因素。與此一致的是，消費者對口乾症早期診斷意識的不斷提高、醫療保健支出的顯著增加以及多樣化診斷技術的出現正在推動市場成長。此外，政府為提高消費者對口乾症及其症狀、原因和治療的認知而採取的有利舉措正在推動市場成長。除此之外，各種治療藥物的容易取得以及持續的研發（R＆D）活動正在為市場創造積極的前景。

本報告回答的關鍵問題

全球口乾症（口乾症）治療市場有多大？
2023-2028年全球口乾症（口乾症）治療市場的預期成長率為何？
推動全球口乾症（口乾症）治療市場的關鍵因素是什麼？
COVID-19 對全球口乾症（口乾症）治療市場有何影響？
全球口乾症（口乾病）治療市場按類型分類是怎樣的？
根據藥物類型，全球口乾症（口乾症）治療市場的詳細情形如何？
基於配銷通路，全球口乾症（口乾病）治療市場的詳細情形如何？
全球口乾症（口乾病）治療市場的關鍵區域有哪些？
全球口乾症（口乾病）治療市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 10 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 13 章：價格分析

第14章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- 3M Company
- Biotene (GSK plc)
- Parnell Pharmaceuticals Inc.
- Quest Products LLC
- Saliwell Ltd
- Sun Pharmaceutical Industries Limited
- West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)

簡介目錄圖表

Product Code: SR112023A6439

Abstract

Market Overview:

The global xerostomia (dry mouth disease) therapeutics market size reached US$ 714 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 893 Million by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028.

Xerostomia, or dry mouth, refers to symptoms or sensations of oral dryness that are usually caused due to a decrease in the amount of saliva. This condition is triggered by the adverse effects of radioactivity in the neck and head, increasing consumption of antianxiety drugs, dehydration, diabetes, and Alzheimer's disorder. It can be treated with the support of salivary pens or stimulants, artificial saliva, prescribed medications, and home remedies, including sipping water and moisturizing lips. Apart from this, the early diagnosis of salivary glands by practitioners and the usage of recommended mouth moisturizing products, such as over-the-counter (OTC) rinsing, can assist in lubricating the mouth. These treatments alleviate discomfort, prevent severe complications, fix taste disorders, and mitigate bad breath and taste disorders. Consequently, xerostomia therapeutics are used across several hospitals and clinics to deal with decreased salivary gland function.

Xerostomia (Dry Mouth Disease) Therapeutics Market Trends:

The increasing incidences of dry mouth, especially amongst the geriatric population, due to medicine side-effects of radiotherapy and chemotherapy and the rising need for dry mouth relief products are primarily driving the market growth. Additionally, the growing uptake of several prescription-based toothpaste, vitamin gummies, and medicines for treating Sjogren's syndrome, Alzheimer's diseases, and human immunodeficiency virus (HIV) that cause xerostomia is acting as another growth-inducing factor. In line with this, the rising consumer awareness regarding the early diagnosis of xerostomia, significant enhancements in healthcare expenditure, and the advent of diverse diagnostic technologies are propelling the market growth. Moreover, the favorable initiatives being commenced by governments to sensitize consumers regarding the xerostomia disease, its symptoms, causes, and treatments are impelling the market growth. Apart from this, the easy availability of various therapeutic drugs and ongoing research and development (R&D) activities are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global xerostomia (dry mouth disease) therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, drug type and distribution channel.

Breakup by Type:

Artificial Saliva/Saliva Substitutes

Salivary Stimulants

Breakup by Drug Type:

OTC

Prescription

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).

Key Questions Answered in This Report

1. How big is the global xerostomia (dry mouth disease) therapeutics market?
2. What is the expected growth rate of the global xerostomia (dry mouth disease) therapeutics market during 2023-2028?
3. What are the key factors driving the global xerostomia (dry mouth disease) therapeutics market?
4. What has been the impact of COVID-19 on the global xerostomia (dry mouth disease) therapeutics market?
5. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on type?
6. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the drug type?
7. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the distribution channel?
8. What are the key regions in the global xerostomia (dry mouth disease) therapeutics market?
9. Who are the key players/companies in the global xerostomia (dry mouth disease) therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Xerostomia (Dry Mouth Disease) Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Artificial Saliva/Saliva Substitutes
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Salivary Stimulants
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Drug Type

7.1 OTC
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Prescription
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Hospital Pharmacy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Retail Pharmacy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Online Pharmacy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 3M Company
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Biotene (GSK plc)
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Parnell Pharmaceuticals Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
- 14.3.4 Quest Products LLC
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Saliwell Ltd
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Sun Pharmaceutical Industries Limited
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Xerostomia Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Xerostomia Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Xerostomia Therapeutics Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Xerostomia Therapeutics Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Xerostomia Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Xerostomia Therapeutics (Salivary Stimulants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Xerostomia Therapeutics (Salivary Stimulants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Xerostomia Therapeutics (OTC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Xerostomia Therapeutics (OTC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Xerostomia Therapeutics (Prescription) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Xerostomia Therapeutics (Prescription) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Xerostomia Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Xerostomia Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Xerostomia Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Xerostomia Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: North America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: North America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: United States: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: United States: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Canada: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Canada: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Asia-Pacific: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Asia-Pacific: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: China: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: China: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Japan: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Japan: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: India: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: India: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: South Korea: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: South Korea: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Australia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Australia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Indonesia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Indonesia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Europe: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Europe: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Germany: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Germany: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: France: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: France: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: United Kingdom: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: United Kingdom: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Italy: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Italy: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Spain: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Spain: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Russia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Russia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Latin America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Latin America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Brazil: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Brazil: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Mexico: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Mexico: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Middle East and Africa: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Middle East and Africa: Xerostomia Therapeutics Market: Breakup by Country (in %), 2022
Figure 70: Middle East and Africa: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Global: Xerostomia Therapeutics Industry: SWOT Analysis
Figure 72: Global: Xerostomia Therapeutics Industry: Value Chain Analysis
Figure 73: Global: Xerostomia Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Xerostomia Therapeutics Market: Key Industry Highlights 2022 and 2028
Table 2: Global: Xerostomia Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Xerostomia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: Global: Xerostomia Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Xerostomia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Xerostomia Therapeutics Market: Competitive Structure
Table 7: Global: Xerostomia Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219